NCT06200883View on ClinicalTrials.gov

Effects of a Nutraceutic Compound on Cognitive Impairment

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 1, 2023

Study Completion Date

November 1, 2023

Conditions
Mild Cognitive Impairment
Interventions
DRUG

Placebo oral vial

In the Placebo group the participants take vehicle (1 vial per os every 24 hours) for 4 weeks

DRUG

Choline Bitartrate

In the CEREBRAIN group the participants take CEREBRAIN (1 vial per os of 1.2 g every 24 hours) for 4 weeks

Trial Locations (1)

80131

Ambulatorio Ipertensione e Unità Coronarica Federico II University, Napoli

All Listed Sponsors
lead

Federico II University

OTHER